ORINASE DIAGNOSTIC Drug Patent Profile
✉ Email this page to a colleague
When do Orinase Diagnostic patents expire, and when can generic versions of Orinase Diagnostic launch?
Orinase Diagnostic is a drug marketed by Pharmacia And Upjohn and is included in one NDA.
The generic ingredient in ORINASE DIAGNOSTIC is tolbutamide sodium. There are fifteen drug master file entries for this compound. Additional details are available on the tolbutamide sodium profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for ORINASE DIAGNOSTIC?
- What are the global sales for ORINASE DIAGNOSTIC?
- What is Average Wholesale Price for ORINASE DIAGNOSTIC?
Summary for ORINASE DIAGNOSTIC
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 19 |
| Patent Applications: | 25 |
| DailyMed Link: | ORINASE DIAGNOSTIC at DailyMed |
US Patents and Regulatory Information for ORINASE DIAGNOSTIC
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pharmacia And Upjohn | ORINASE DIAGNOSTIC | tolbutamide sodium | INJECTABLE;INJECTION | 012095-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
